Clinical Trial Update: Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the impact of Rifampicin on treatment outcomes for Cutibacterium acnes prosthetic joint infections is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections of Prosthetic Joint

Drugs mentioned

• Rifampicin

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Infections Joint Prosthetic | Phase 3 | Status: NOT_YET_RECRUITING